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 FadD is an acyl-coenzyme A (CoA) synthetase responsible for the activation of 21 
exogenous long chain fatty acids (LCFA) into acyl-CoAs. Mutation of fadD in the 22 
symbiotic nitrogen-fixing bacterium Sinorhizobium meliloti promotes swarming 23 
motility and leads to defects in nodulation of alfalfa plants. In this study, we found 24 
that S. meliloti fadD mutants accumulate a mixture of free fatty acids during the 25 
stationary phase of growth. The composition of the free fatty acid pool together with 26 
the results obtained after specific labeling of esterified fatty acids with a Δ5-27 
desaturase are in agreement with membrane phospholipids being the origin of the 28 
released fatty acids. Escherichia coli fadD mutants also accumulate free fatty acids 29 
released from membrane lipids in the stationary phase. This phenomenon does not 30 
occur in a mutant of E. coli in the fatty acid transporter FadL, suggesting that the 31 
accumulation of fatty acids in fadD mutants occurs inside the cell. Our results 32 
indicate that, besides the activation of exogenous LCFA, in bacteria FadD plays a 33 
major role in the activation of endogenous fatty acids released from membrane 34 
lipids. Furthermore, expression analysis performed in S. meliloti revealed that a 35 
functional FadD is required for the up-regulation of genes involved in fatty acid 36 
degradation and suggest that in the wild type strain, the fatty acids released from 37 
membrane lipids are degraded by β-oxidation in the stationary phase of growth. 38 
39 
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The model microorganism Escherichia coli can grow using long chain fatty acids 40 
(LCFA) as the sole carbon source. LCFA (> 10 carbons) are transported into the cell by 41 
the outer membrane protein FadL and subsequently converted to their coenzyme A (CoA) 42 
thioesters by acyl-CoA synthetase, encoded by fadD (40). Degradation of acyl-CoAs 43 
proceeds via an inducible set of enzymes that catalyze the β-oxidative cleavage of the 44 
acyl-CoA into acetyl-CoAs. The first step in the β-oxidation cycle involves the 45 
conversion of acyl-CoA to enoyl-CoA via FadE. The remaining steps of hydration, 46 
oxidation and thiolytic cleavage in fatty acid degradation are performed by a tetrameric 47 
complex consisting of two copies each of FadA and FadB (reviewed in 40). Strains 48 
mutated in fadD cannot produce acyl-CoA and thus cannot grow on exogenous LCFA 49 
(40). Mutant strains with a deletion of the fadL gene cannot transport LCFA across the 50 
cell envelope and, therefore, cannot grow on LCFA; yet they retain the ability to β-51 
oxidize LCFA in vitro (8). 52 
 Mutants of Saccharomyces cerevisiae with the combined deletion of faa1 and faa4, 53 
encoding for two acyl-CoA synthetases, secrete fatty acids (44). Cyanobacteria are able 54 
to incorporate exogenous fatty acids, although they seem to be devoid of an acyl-CoA 55 
synthetase activity. Instead, they contain an acyl-acyl carrier protein synthetase (Aas) 56 
activity, which catalyzes the ATP-dependent esterification of fatty acids to acyl carrier 57 
protein (23). Mutants of cyanobacteria in Aas are unable to utilize exogenous fatty acids 58 
and secrete endogenous fatty acids into the culture medium (23). In both cases, S. 59 
cerevisae mutants defective in acyl-CoA synthetases and the cyanobacterial Aas mutants, 60 
was established that released fatty acids originate from membrane lipids (23, 44). It was 61 
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proposed that the fatty acids are released as a consequence of lipid remodeling when fatty 62 
acid residues are exchanged (23, 44).  63 
Recently we have identified a different process of lipid remodeling in 64 
Sinorhizobium meliloti that involves the polar head group of membrane lipids instead of 65 
fatty acids (50). Under growth conditions of sufficient phosphate, 95% of the membrane 66 
lipids of S. meliloti are phospholipids consisting of phosphatidylcholine, 67 
phosphatidylethanolamine (PE), monomethyl-PE, dimethyl-PE, phosphatidylglycerol, 68 
and cardiolipin. However, under phosphorus-limiting conditions, S. meliloti 1021 is able 69 
to remodel existing phospholipids to convert most of them into phosphorus-free 70 
membrane lipids (50). The outer leaflet of the outer membrane in Gram-negative bacteria 71 
contains minor amounts of phospholipids but is mainly composed of lipopolysaccharides 72 
(LPS). LPS consist of three structural regions where the lipid A region provides the 73 
hydrophobic part that anchors the LPS to the outer membrane. Remarkably, 3-hydroxy-74 
fatty acids are part of the lipid A structure while such fatty acids do ussually not appear in 75 
phospholipids. Several studies have shown the importance of LPS for S. meliloti (6, 17, 76 
45)  77 
In several bacteria, a mutation in fadD provokes phenotypes apparently unrelated to 78 
the function of FadD as an enzyme required for growth on LCFA (5, 31, 48). A mutant of 79 
Streptomyces coelicolor in fadD1 shows a severe deficiency in the production of the 80 
antibiotic actinorhodin (Atc) that seems to be related to a delayed expression of the act 81 
biosynthetic genes (5). In Salmonella enterica serovar Typhimurium, a mutation in fadD 82 
represses the expression of HilA, an activator of invasion genes (31). The lack of fadD in 83 
Sinorhizobium meliloti GR4 results in multicellular swarming behavior and defects in the 84 
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establishment of its symbiosis with alfalfa (48). Swarming is a type of bacterial motility 85 
characterized by a rapid and coordinated population migration across a surface and 86 
involves a complex process of differentiation in which cells usually become 87 
hyperflagellated and elongated (18). Interestingly, mutants of Pseudomonas aeruginosa 88 
in fadD1 also showed an increased swarming motility (24) and mutants in fadD of Vibrio 89 
cholerae showed a repression of the major virulence genes as well as an increase in 90 
motility (37). 91 
Although the wild type strain of S. meliloti GR4 never shows swarming motility, 92 
the S. meliloti wild type strains 1021 and 2011 present a surface movement resembling 93 
that of the fadD mutants in approximately 70% of the experiments (33). In all three S. 94 
meliloti strains, a mutation in fadD promotes swarming motility (33). Furthermore, it was 95 
demonstrated that genes required for the biosynthesis of the siderophore rhizobactin 1021 96 
are essential for swarming in the wild type strains but they are dispensable in a fadD 97 
mutant background (33). Given the function of FadD in fatty acid metabolism, we 98 
investigated the lipidic composition of S. meliloti wild type and fadD mutant strains. We 99 
found that the fadD mutant of S. meliloti accumulates significant amounts of free fatty 100 
acids in the stationary phase of growth. Several lines of evidence support that the fatty 101 
acids accumulated in the fadD mutant are derived from complex membrane lipids. We 102 
propose that a major function of FadD is the utilization of endogenous free fatty acids 103 
that could have been released as a result of lipid remodeling. 104 
105 
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MATERIALS AND METHODS 106 
Bacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids 107 
used in this work and their relevant characteristics are listed in Table 1. Mutations of 108 
fadD or fadL genes in E. coli Y-Mel or in K27 (pBBR1MCS-3) were transduced from 109 
strains in the Keio Collection (4) by P1vir transduction (49). Correct transfer of the fadL 110 
mutation in strains YfadL1 and KfadL1 was corroborated using K2 oligonucleotide (4) 111 
and an oligonucleotide that matches the last 21 nucleotides of the fadL gene (data not 112 
shown) in a PCR reaction and amplifying a fragment of the expected size. E. coli strains 113 
were grown at 30°C either in Luria-Bertani (LB) broth (43) or in M9 minimal medium 114 
(32).  S. meliloti strains were grown at 30°C either in complex tryptone yeast (TY) broth 115 
supplemented with 4.5 mM CaCl2 (7) or in the minimal media Sherwood (46) with 116 
succinate (8.3 mM) replacing mannitol as the carbon source, or Robertsen (39). 117 
Antibiotics were added, when required, to the following final concentrations (μg ml-1): 118 
carbenicillin, 100, and tetracycline, 20 for E. coli, and streptomycin, 200, kanamycin, 200 119 
and tetracycline, 8 for S. meliloti.  120 
DNA manipulations. Recombinant DNA techniques were carried out using standard 121 
procedures (43). The gene Δ5-des was amplified from plasmid pDM10 (1) using the 122 
specific oligonucleotides 5’-AGGAATACATATGACTGAACAAACCATTGCAC-3’ 123 
and 5’-AAAGGATCCTCAGGCATTCTTCCGCAGC-3’. The forward primer 124 
incorporated an NdeI restriction site (underlined) overlapping the start codon of the gene 125 
and the reverse primer incorporated a BamHI restriction site (underlined) after the stop 126 
codon. After digestion of the amplified fragment with NdeI and BamHI, it was cloned 127 
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into pET17b that had been digested with the same enzymes resulting in plasmid pECH9. 128 
Plasmid pECH9 was linearized with BamHI and cloned into pRK404 previously digested 129 
with BamHI resulting in plasmid pRCanul5. As a control, pET17b was linearized with 130 
BamHI and cloned into pRK404 previously digested with the same enzyme resulting in 131 
plasmid pNG28. pRCanul5 or pNG28 were mobilized into S. meliloti 1021FDC5 by 132 
biparental mating using the E. coli S17-1 donor strain as described previously (47). 133 
In vivo labeling of S. meliloti and E. coli with 14C-acetate and analysis of lipid 134 
extracts by TLC. The lipid composition of the different S. meliloti and E. coli strains 135 
was determined following labeling with [1-14C]-acetate. Cultures (1 ml) were inoculated 136 
at an initial OD620= 0.1 from precultures grown in the same medium. After the addition of 137 
2 μCi [1-14C]-acetate (60 mCi mmol-1) to each culture, they were incubated to distinct 138 
time points in different growth phases. The cells were harvested by centrifugation, 139 
washed with 500 μl of water and resuspended in 100 μl of water. The lipids were 140 
extracted according to the method of Bligh & Dyer (9). The chloroform phase was used 141 
for lipid analysis by one-dimensional thin layer chromatography (TLC) using high 142 
performance TLC silica gel 60 plates (Merck) and as mobile phase ethyl 143 
acetate:hexane:acetic acid (60:40:5, v:v:v). Two-dimensional TLC was performed as 144 
described previously (12). Radioactivity was detected using a Storm 820 Phosphorimager 145 
(Amersham Biosciences). Image analysis and signal quantification was carried out using 146 
ImageQuant TL (Amersham Biosciences). 147 
Fatty acids analysis. For fatty acid analysis, 20 ml cultures were grown until early 148 
stationary phase for S. meliloti or till late stationary phase for E. coli. Cells and culture 149 
media were separated by centrifugation at 6,000 g for 15 min. Cell pellets were 150 
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resuspended in 1 ml of water and extracted according to Bligh and Dyer (9). To 151 
distinguish between free and esterified fatty acids in cellular lipid extracts, samples were 152 
split in two equivalent parts and treated with two different reagents which resulted in 153 
either specific methylation of free fatty acids or in transmethylation of esterified fatty 154 
acids (44). Fatty acids from spent supernatants were extracted twice with equal volumes 155 
of acidified ethyl acetate (0.1 ml l-1 glacial acetic acid) and they were subsequently 156 
converted to methyl esters as described (44). Ten μg of tridecanoic acid (C13:0) were 157 
added as internal standard. The methyl esters were extracted twice with 1 ml of hexane 158 
each time followed by centrifugation. The upper hexane phases were pooled into a new 159 
glass vial and dried under a nitrogen stream.   160 
For quantitative analysis, fatty acid methyl esters were dissolved in 600 μl hexane 161 
(HPLC/spectrophotometric grade) and 1 μl was used for analysis by gas chromatography 162 
(GC 6890 Agilent Technologies, Santa Clara, CA, U.S.A.) coupled to mass spectrometric 163 
detection (Quadrupole MSD HP 5973, Agilent Technologies, Santa Clara, CA). Samples 164 
were separated in a 5% phenyl, 95% methylpolysiloxane capillary column (HP-5MS, 165 
Agilent Technologies, Santa Clara, CA, 25 m x 0.200 mm x 0.33 μm film thickness). The 166 
oven was set at 100°C for 2 min and the following gradient was used: 100 ºC  to 244 ºC 167 
at 5 ºC min-1 and held at 244 ºC for 10 min. Helium was used as the carrier gas, with a 168 
flow rate of 40 cm s-1 at 100 ºC. The molecules were ionized by electron impact at 70 eV.  169 
Fatty acid species were identified using retention times and mass spectral information by 170 
comparison with the bacterial acid methyl esters mix standard (BAME 47080-U, Sigma-171 
Aldrich). The relative amounts of fatty acid methyl esters were determined by comparing 172 
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the areas under the peaks on the chromatogram to the area under the peak of the internal 173 
fatty acid standard (C13:0). 174 
RNA isolation and synthesis of labeled DNA. For RNA isolation, preinocula of  175 
1021 and 1021FDC5 cells were grown at 30ºC in 3 ml of TY broth to late exponential 176 
phase (OD620 nm = 1.0-1.1). After incubation, 1 ml of each culture was pelleted, washed 177 
twice in Robertsen minimal medium and resuspended in the same volume of the latter 178 
medium. Erlenmeyer flasks (250 ml) containing 30 ml of liquid Robertsen medium were 179 
inoculated with 0.3 ml of the rhizobial suspension and incubated at 30ºC with continuous 180 
shaking (190 r.p.m.) until reaching either an OD620 nm = 0.7-0.8 (mid exponential phase of 181 
growth) or an OD620 nm = 1.1-1.2 (beginning of stationary phase of growth). Cells were 182 
harvested by centrifugation, washed with 0.1% sarkosyl and the cell pellets were 183 
immediately frozen in liquid nitrogen and conserved at -80ºC until RNA isolation. For 184 
microarray hybridization and reverse transcription quantitative real-time PCR (RT-185 
qPCR), RNA was isolated using the Qiagen RNeasy RNA purification kit (Qiagen) 186 
following the manufacturer’s instructions. Residual DNA was removed with RNase-free 187 
DNase I Set (ROCHE). The quality of the RNA was checked by 1.4% agarose gel 188 
electrophoresis. 189 
Cy3- and Cy5-labeled cDNAs were prepared according to DeRisi et al. (13) from 15 190 
µg of total RNA. Three slide hybridizations were performed using the labeled cDNA 191 
synthesized from each of the RNA preparations from three independent bacterial cultures. 192 
Microarray hybridization, image acquisition, and data analysis. Sm6koligo 193 
microarrays were purchased from A. Becker (University of Bielefeld, Bielefeld, 194 
Germany). Hybridizations were performed as described previously (15). For image 195 
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acquisition a GenePix 4100A Scanner (Axon Instruments, Inc., Foster City, CA, USA) 196 
was used. Quantifications of mean signal intensities for each spot were determined using 197 
the GenePix Pro 5.0 software (Axon Instruments, Inc.). Normalization and t-statistics 198 
were carried out using the EMMA 2.6 microarray data analysis software developed at the 199 
Bioinformatics Resource Facility Center for Biotechnology, Bielefeld University 200 
(http://www.genetik.uni-bielefeld.de/EMMA/) (16). Three independent biological 201 
replicates were performed for each experiment. Genes were regarded as differentially 202 
expressed if they showed p≤0.05, A≥7 and M≥1 or M≤-1 (A, average signal to noise; M 203 
value is log2 experiment/control ratio). Detailed protocols and raw data resulting from the 204 
microarray experiments have been deposited in the ArrayExpress database with the 205 
accession number E-MEXP-2651. 206 
Reverse transcription quantitative real-time PCR (RT-qPCR). Total RNA (1 µg) 207 
treated with RNase-free DNase I Set (ROCHE) was reversely transcribed using 208 
Superscript II reverse transcriptase (INVITROGEN) and random hexamers (ROCHE) as 209 
primers. Quantitative real-time PCR was performed on an iCycler iQ5 (Bio-Rad, 210 
Hercules, CA, USA). Each 25 µl reaction contained either 1 µl of the cDNA or a dilution 211 
(1:10,000, for amplification of the 16S rRNA gene), 200 nM of each primer and iQ 212 
SyBrGreen Supermix (BioRad). Control PCR reactions of the RNA samples not treated 213 
with reverse transcriptase were also performed to confirm the absence of contaminating 214 
genomic DNA. Samples were initially denatured by heating at 95 ºC for 3 min followed 215 
by a 35-cycle amplification and quantification program (95 ºC for 30 s, 55 ºC for 45 s, 216 
and 72 ºC for 45 s). A melting curve was conducted to ensure amplification of a single 217 
product. The oligonucleotide sequences for qPCR are listed in Table 2. The efficiency for 218 
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each primer pair (E) was determined by running 10-fold serial dilutions (4 dilution series) 219 
of 1021 genomic DNA as template and generating a standard curve by plotting the log of 220 
the dilution factor against the CT value during amplification of each dilution. 221 
Amplification efficiency is calculated using the formula (E=[10(1/a)-1]x100) where a is 222 
the slope of the standard curve. 223 
The relative expression of each gene was normalized to that of 16S rRNA and the 224 
analysis of results was done using the comparative critical threshold (∆∆CT) method (36).  225 
 226 
RESULTS 227 
Sinorhizobium meliloti fadD mutants accumulate free fatty acids in the 228 
stationary phase of growth. The gene fadD encodes a long-chain fatty acyl-CoA 229 
synthetase and in order to follow fatty acid metabolism in S. meliloti wild type and fadD 230 
mutant, we grew cultures of them in the presence of 14C-acetate. Lipid extracts obtained 231 
from cultures grown until different time points in the distinct growth phases were first 232 
analyzed by one-dimensional thin layer chromatography (TLC) with  a mobile phase 233 
consisting of ethyl acetate:hexane:acetic acid (60:40:5) to allow separation of the more 234 
hydrophobic compounds. Lipid extracts from cultures of S. meliloti GR4 and its fadD-235 
deficient mutant QS77 grown to exponential phase showed a similar level of a spot that 236 
runs as fatty acids (Fig. 1A and 1C). However, the extract of cultures grown to early or 237 
late stationary phases showed a significant increase in the spot for  fatty acids in strain 238 
QS77 while this spot was barely detected in lipid extracts from the wild type GR4 (Fig. 239 
1A and 1C). Also, the accumulation of a compound migrating like fatty acids was 240 
observed in lipid extracts obtained from the S. meliloti fadD mutant strain derived from 241 
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the sequenced S. meliloti 1021 strain grown to the early stationary phase of growth (Fig. 242 
1B). Furthermore, complementation of QS77 with the fadD-bearing plasmid pBBRD4 243 
abolished the accumulation of fatty acids while QS77 carrying an empty plasmid 244 
(pBBR1MCS-3) still accumulated fatty acids (Fig. 1B). Therefore, the accumulation of 245 
fatty acids in stationary phase of growth is directly related to the absence of fadD.  246 
In Fig. 1C, the growth behavior of strain GR4 and its fadD mutant is shown in 247 
relation to the content of fatty acids. Similar results were obtained with wild type strain 248 
1021 and its fadD-deficient mutant 1021FDC5 (data not shown). A two-dimensional TLC 249 
analysis of lipid extracts from 1021 and its fadD-deficient mutant 1021FDC5 grown till 250 
early stationary phase showed no difference with respect to major membrane lipids, but 251 
revealed clearly the accumulation of fatty acids in the mutant (Fig. 2).  252 
The compound accumulated in the fadD mutants comigrated in different separation 253 
systems as free fatty acids (Figs. 1 and 2). Therefore, we proceeded to analyze the content 254 
of free fatty acids on lipid extracts from wild type 1021 and its fadD-deficient derivative 255 
1021FDC5 that had been grown on minimal medium to the early stationary phase. The 256 
concentration of free fatty acids in lipid extracts obtained from cell pellets was 257 
significantly higher in the mutant compared to the wild type. The lipid extract of the 258 
fadD-deficient mutant contained relative concentrations of total free fatty acids 259 
corresponding to 102.6 (SD 36.7) nmol ml-1 of culture while samples of the wild type 260 
strain contained only 0.75 (SD 0.24) nmol ml-1 (Table S1). Clearly, the mutation in fadD 261 
resulted in a significant accumulation of cell-associated free fatty acids. The most 262 
abundant fatty acid accumulated in the fadD mutant was cis-vaccenic acid (C18:1, Δ11), 263 
comprising more than 60% of the total fatty acids. Following in abundance were palmitic 264 
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acid (C16:0, 26.4%), stearic acid (C18:0, 5.8%) and lactoballic acid (C19:0cp, 5.0%) 265 
(Fig. 3A; Table S1). These are the same fatty acids found typically esterified to 266 
membrane lipids of S. meliloti (39). We quantified the esterified fatty acids in the cellular 267 
lipid extracts of 1021 and its fadD mutant and found that the pattern of esterified fatty 268 
acids present in both strains was similar (Fig. 3B; Table S1). Furthermore, the 269 
composition of free fatty acids accumulated in 1021FDC5 reflected the composition of 270 
fatty acids esterified to membrane lipids (Fig. 3A and B). Also, a modest accumulation of 271 
free fatty acids was observed in supernatants of cultures of the fadD mutant. A total of 272 
3.15 (SD 0.55) nmol ml-1 of fatty acids were present in the culture medium of the mutant 273 
versus 0.31 (SD 0.06) nmol ml-1 present in that of the wild type (Table S1). Besides 274 
detecting fatty acids usually known to be esterified to membrane phospholipids, the 275 
supernatant of the mutant strain contained significant amounts of myristic (C14:0) and 3-276 
hydroxymyristic (3-OH-C14:0) acids (Fig. 3C; Table S1). In particular, 3-OH-C14:0 277 
amounted to 15.5% of the total free fatty acids present in the spent culture medium. This 278 
is remarkable as 3-OH-C14:0 is the most abundant fatty acid in lipid A of S. meliloti (17, 279 
45) and it might be found in the medium due to release from lipid A.  Less abundant, 280 
each one comprising from 1 to 3.8% of the total, were the fatty acids C12:0, C14:1, 281 
C20:0 and C18:0 epoxide.  282 
The accumulated free fatty acids derive from complex membrane lipids. The 283 
free fatty acids identified in cellular lipid extracts from the fadD mutant reflected the 284 
composition of the fatty acids usually esterified to membrane lipids (Fig. 3; Table S1). 285 
The detection of cyclopropane fatty acids (C17:0cp and C19:0cp) in the free fatty acid 286 
fraction is remarkable as cyclopropanation in fatty acids is introduced by cyclopropane 287 
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fatty acid synthases on fatty acyl residues that are esterified to membrane lipids (20). The 288 
presence of the cyclopropane fatty acids in the culture medium and in the cell lipid 289 
extracts strongly suggested that these fatty acids had been released from complex 290 
membrane lipids.  291 
With the aim to get additional proof about the metabolic origin of the free fatty acids, 292 
we followed a similar strategy to that described for yeast by Scharnewski and co-workers 293 
(44). This strategy consists in introducing a fatty acid modification that occurs only when 294 
fatty acids are substituents of membrane phospholipids. We introduced the gene coding 295 
for Δ5-Des lipid desaturase from Bacillus subtilis into the fadD mutant 1021FDC5. Δ5-296 
Des is a membrane-bound acyl desaturase that introduces a cis-double bond between the 297 
5 and 6 position of fatty acyl residues attached to membrane lipids (2). The analysis by 298 
gas chromatography of methyl esters obtained from free fatty acids in the spent culture 299 
medium of 1021FDC5 expressing Δ5-des showed the presence of two additional peaks 300 
that were not present in the same fraction of 1021FDC5 carrying an empty vector (Fig. 301 
4). The new peaks were identified as C16:1, Δ5 and C18:2, Δ5, Δ11 based on comparison 302 
of the mass spectra we obtained with those reported for the methyl ester of C16:1, Δ5 303 
(34) and for the methyl ester of C18:2, Δ5, Δ11 (10) (Figs. S1 and S2, respectively). The 304 
capacity of Δ5-Des to produce C18:2, Δ5, Δ11 was demonstrated previously after 305 
overexpression of the enzyme in E. coli (10). Expression of Δ5-des in the S. meliloti fadD 306 
mutant strain resulted in an abundance of 5.5% of Δ5-modified fatty acids in the pool of 307 
esterified fatty acids, indicating successful expression of the Δ5-desaturase (data not 308 
shown). More interestingly, 1.5% of the free fatty acids of the cell lipid extract (data not 309 
shown) and 3% of free fatty acids in the culture medium (Fig. 4) contained Δ5-modified 310 
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fatty acids. These findings indicate a release of the modified lipid-bound fatty acyl 311 
residues into the pool of free fatty acids and suggest that the accumulation of free fatty 312 
acids is the result of the release of fatty acyl residues from membrane lipids. 313 
Fatty acid release also occurs in Escherichia coli. E. coli is the model organism 314 
where bacterial fatty acid metabolism has been studied most extensively. Since mutants 315 
in fadD of E. coli are available, we wanted to explore if the phenomenon of release of 316 
fatty acids from membrane lipids also occurs in this organism. We first analyzed lipid 317 
extracts after labeling of E. coli cultures in minimal medium. Similarly as observed for S. 318 
meliloti, there was no difference with respect to the accumulation of free fatty acids 319 
during the exponential phase of growth (Fig. 5A). Also no significant accumulation of 320 
fatty acids could be observed in an E. coli fadD mutant in the early stationary phase of 321 
growth (OD=1.2, 9 hours of growth; Fig. 5A). However, at 26 hours of growth (15 hours 322 
after entering the stationary phase) a significant amount of free fatty acids were detected 323 
in lipid extracts of the fadD mutants (Fig. 5). In contrast to the fadD mutant, lipid extracts 324 
of the late stationary phase of the E. coli wild type or the fadD mutant complemented 325 
with fadD from S. meliloti did not show fatty acid accumulation (Fig. 5). We next 326 
quantified free fatty acids and esterified fatty acids in the E. coli fadD mutant carrying a 327 
vector or carrying the same vector with fadD of S. meliloti from cultures grown in 328 
minimal medium till late stationary phase. The cellular lipid extract of the fadD mutant 329 
contained a total of 46.2 (SD 3.4) nmol of free fatty acids ml-1of culture while the lipid 330 
extract of the complemented strain contained only a total of 0.33 (SD 0.08) nmol ml-1 331 
culture (Table S2). Remarkably, cis-vaccenic acid (C18:1, Δ11) amounts to 19% of the 332 
total in the free fatty acid pool which is in stark contrast to its presence of less than 1% in 333 
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the pool of esterified fatty acids (Fig. 6A and B). The other free fatty acids of the lipid 334 
extract reflect the composition of the esterified fatty acids (Fig. 6A and B; Table S2). The 335 
free fatty acids present in the culture medium of the E. coli fadD mutant are similar to the 336 
free fatty acids present in the cellular lipid extract with the major difference that 3-337 
hydroxymyristic acid (3-OH-C14:0) is 5% of the free fatty acids in the culture medium 338 
and is only 0.1% in the cell-associated lipid extract (Fig. 6; Table S2). The sum of 339 
cyclopropane fatty acids (C17:0cp and C19:0cp) in both fractions of free fatty acids 340 
consisted of about 25% of the total fatty acids (Fig. 6A and C; Table S2). The presence of 341 
these cyclopropane fatty acids in the free form strongly suggests that they had been 342 
released from membrane phospholipids since the cyclopropane fatty acid synthase of E. 343 
coli only modifies monounsaturated fatty acids that are lipid-bound (20). The spectrum of 344 
free fatty acids found in the E. coli fadD-mutant is similar to the spectrum of esterified 345 
fatty acids but it is not identical. This can be explained by the fact that esterified fatty 346 
acids continue to be modified but not the free fatty acids which had been released from 347 
the membrane lipid during the distinct growth phases. Since cultures of E. coli were 348 
collected in late stationary phase most of the monounsaturated fatty acids in the lipid-349 
bound fraction have been converted to their cyclopropane forms. 350 
The accumulation of free fatty acids observed in both E. coli and S. meliloti fadD 351 
mutants could be explained as a result of lysis of some cells during the stationary phase 352 
of growth. However, comparison of OD and colony forming units (cfu) values of wild 353 
type and mutant strains at the point where fatty acids were measured do not support this 354 
hypothesis (data not shown). Moreover, if fatty acids accumulating in the fadD mutant 355 
were from an extracellular origin, i.e. from cellular lysis, the accumulation of fatty acids 356 
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should also be observed in an E. coli fadL mutant, which is unable to incorporate 357 
exogenously supplied LCFA. To test this hypothesis E. coli fadD, fadL and fadDfadL 358 
mutants were constructed by transduction. These mutants, in contrast to wild type E. coli, 359 
were unable to grow in oleate as a sole carbon source. Furthermore, the incorporation of 360 
14C-palmitic acid in the mutant strains was as expected for deficiencies in fadD or fadL 361 
(41). Also in our hands, the fadD mutant incorporated fatty acids only into 362 
phosphatidylethanolamine (data not shown). In contrast, due to the impaired uptake of 363 
palmitic acid, we hardly observed any incorporation of fatty acids into the phospholipids 364 
of the fadL mutant (data not shown). Whereas free fatty acids accumulate in a fadD 365 
mutant, a fadL mutant did not show such an accumulation of fatty acids in cells or in 366 
spent medium (Fig. 5B). The fact that fatty acids do not accumulate and must therefore be 367 
consumed in a fadL mutant, strongly suggests that fatty acids accumulated in the fadD 368 
mutant are of intracellular origin. The consumption of fatty acids in a fadL mutant is in 369 
agreement with its reported capability of performing β-oxidation in vitro (8). 370 
Furthermore, a double fadDfadL mutant also accumulates fatty acids in the cell-371 
associated fraction (Fig. 5B), indicating again an intracellular nature of the accumulated 372 
fatty acids because in this strain transport of fatty acids from the outside is impaired. 373 
FadD is required for the up-regulation of S. meliloti fatty acid degradation (fad) 374 
genes in the stationary phase of growth. The differences observed in accumulation of 375 
fatty acids between the fadD mutant and wild type strains, prompted us to compare the 376 
transcriptome of these two strains in cultures grown in liquid minimal medium at the 377 
beginning of the stationary phase. A total of 128 genes appeared as differentially 378 
expressed under these conditions, with the majority of them (120 genes) showing down-379 
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regulation in the fadD mutant compared to the wild type strain (Table S3). Numbers of 380 
down-regulated genes in each functional category are presented as a histogram in Fig. 7.  381 
Many of the down-regulated genes (26%) have unknown functions or display partial or 382 
global homology to genes deposited in databases (Fig. 7). Moreover, we found down-383 
regulation of a significant number of genes involved in different metabolic activities (Fig. 384 
7; Table S3) suggesting a lower metabolic rate in the fadD mutant as compared to the 385 
wild type strain. Thus, we found down-regulation of genes involved in protein 386 
metabolism (up to 29 genes coding for ribosomal proteins, 3 elongation factors and 3 387 
chaperone genes), elements of different respiratory chains and associated functions (11 388 
genes), the active methyl cycle (4 genes), and fatty acid degradation (3 genes). The lower 389 
expression of the genes belonging to the operon smc02229-fadA-fadB and of genes 390 
encoding elements of different respiratory chains in the fadD mutant compared to the 391 
wild type strain during the stationary phase could indicate a lower level of fatty acid 392 
degradation in the mutant and explain the higher accumulation of fatty acids observed in 393 
this strain under these conditions. SMc02229 has been annotated as a putative acyl-CoA 394 
dehydrogenase which could catalyze the conversion of acyl-CoA to enoyl-CoA, the first 395 
step in the β-oxidation cycle, whereas FadB and FadA participate in the remaining steps 396 
of hydration, oxidation and thiolytic cleavage in fatty acid degradation. Therefore, we 397 
decided to analyze the expression of smc02229 and fadB by performing RT-qPCR in 398 
1021 and 1021FDC5 cultures in exponential and stationary phases of growth (Table 3). 399 
The results obtained indicated that at the beginning of the stationary phase of growth 400 
(OD620 nm = 1.2) both genes showed higher expression in the wild type strain relative to 401 
the fadD mutant, thereby confirming the microarray data. On the other hand, when the 402 
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analyses were performed in cultures of the wild type and mutant strains in exponential 403 
phase of growth (OD620 nm = 0.8), similar expression levels were observed for the two 404 
genes (Table 3). These results are in agreement with the observed pattern of accumulation 405 
of fatty acids (Fig. 1), which shows a similar level in wild type and mutant strains during 406 
the exponential phase but which are consumed in the wild type during the stationary 407 
phase. The RT-qPCR data were also used to obtain the relative expression of the fad 408 
genes in stationary phase versus exponential phase of growth in each of the two genetic 409 
backgrounds. These analyses revealed that in the wild type strain the expression of 410 
smc02229 and fadB is higher in stationary than in exponential phase of growth (33.8 ± 411 
10.7 and 3.4 ± 1, respectively). In contrast, in the fadD mutant a decreased expression of 412 
these genes is observed in stationary phase (-3.88 ± 0.43 and -2.31 ± 0.29, respectively) 413 
which could be due to the lower metabolic rate shown by this strain after entering the 414 
stationary phase of growth. These results suggest that in S. meliloti FadD is required for 415 
the up-regulation of fad genes at the beginning of the stationary phase of growth which in 416 
turn allows for the utilization of endogenous free fatty acids released from membrane 417 
lipids.  418 
Among the non-classified regulators that appeared as down-regulated in the 419 
microarray study is smc01260 (Table S3). Interestingly, Kazakov et al. (25) using a 420 
comparative genomic approach have identified SMc01260 as the candidate 421 
transcriptional factor that might control the fatty acid utilization pathway in S. meliloti 422 
1021. The smc01260 regulon proposed by Kazakov et al (25) comprises 9 operons: 423 
smc02162(fadD), smc02229-smc02228(fadA)-smc02227(fadB), smc00977-smc00976, 424 
smc00041, smc02377(etf), smc00729(etfB1)-smc00728(etfA1)-smc00727(hbdA), 425 




smc02484- smc02485- smc02486-smc02487(lpdA2), smc02391, and smc02150. Genes in 427 
four of these operons, underlined in the previous list, appeared as down-regulated in the 428 
S. meliloti fadD mutant (Table S3). The operons belonging to this regulon are preceded 429 
by a common palindromic 18-bp DNA motif named the ILV box which is supposed to be 430 
the binding site for the transcriptional regulator SMc01260 (25). Upstream of smc01260, 431 
we could also identify a 18 bp sequence that differs only in one nucleotide to the 432 
consensus of the ILV box (Fig. S3), suggesting autoregulation. Our experimental data are 433 
in agreement with the computationally identified regulatory network for fatty acid 434 
degradation in S. meliloti. 435 
 436 
DISCUSSION 437 
We have found that mutation of fadD in S. meliloti or in E. coli provokes the 438 
accumulation of a mixture of free fatty acids in the stationary phase of growth. The 439 
composition of the free fatty acid pool together with the experiments of expression of a 440 
lipid-specific Δ5-desaturase are in agreement with membrane phospholipids being the 441 
origin of the released fatty acids. Radiolabeling experiments indicate that fatty acids are 442 
released from both, wild type and mutant (i.e. Fig. 1, 9 hours of growth). However, the 443 
accumulation observed in the stationary phase of growth occurs in fadD mutants due to 444 
their inability to activate and consume the released fatty acids. Furthermore, we have 445 
shown that a fadL mutant of E. coli does not accumulate fatty acids while a double 446 
fadDfadL mutant still accumulates them. These results demonstrate that released fatty 447 
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acids are of intracellular origin and that their subsequent consumption does not require 448 
uptake. So far, the reason for this fatty acid release is not known. 449 
The higher expression of the fad genes observed in wild type S. meliloti compared 450 
to the fadD mutant, suggests that released fatty acids are directed to fatty acid 451 
degradation. The utilization of these fatty acids by the wild type could provide an extra 452 
carbon source when other sources are depleted. Alternatively, acyl-CoAs could be 453 
converted into storage compounds in stationary phase of growth. For example, 454 
Streptomyces coelicolor forms triacylglycerols as storage compounds and long-chain 455 
acyl-CoAs are used as acyl donors in triacylglycerol biosynthesis (3); however formation 456 
of triacylglycerols has not been reported in S. meliloti. In either case, the wild type should 457 
have a metabolic advantage over a fadD mutant in the stationary phase. Although 458 
survival rates of wild type strain and fadD mutants were very similar at the entry (for S. 459 
meliloti) or 15 hours after entering into the stationary phase (for E. coli), in the case of E. 460 
coli we have found a significant reduction (66%) in the survival rate of the fadD mutant 461 
compared to that of the wild type after extended times in stationary phase (41 hours after 462 
entering the stationary phase). 463 
 Remarkably, the phenotype of fatty acid accumulation that we observed in fadD 464 
mutants of S. meliloti and of E. coli was already reported for mutants of S. cerevisae and 465 
of cyanobacteria that are also deficient in their respective systems of fatty acid activation 466 
(23, 44). In both cases, release of fatty acids from membrane lipids was postulated to be 467 
due to a process of lipid remodeling consisting of an exchange of fatty acyl residues (23, 468 
44). So far, little is known about this type of lipid remodeling in the phospholipids of 469 
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bacteria. Direct evidence for phospholipid remodeling by fatty acyl exchange in E. coli 470 
was obtained by Kol and coworkers (26). They demonstrated that exogenously added 471 
short-chain PE to a PE-deficient mutant was remodeled to the typical PE-fatty acyl 472 
profile of the wild type strain. Similar experiments were carried out in Synechocystis 473 
PCC6803. Exogenously added dioleoylphosphatidylglycerol to a phosphatidylglycerol 474 
(PG)-deficient mutant led to the formation of new retailored PG species according to the 475 
functional needs of the cyanobacterium (28). Release of fatty acids from phospholipids 476 
involves the activity of phospholipases type A. A future challenge will be to assign the 477 
corresponding ORFs that are responsible for such activities. While there is no ORF 478 
assigned as phospholipase A in the genome of S. meliloti, in E. coli two different 479 
phospholipase A activities are described but the biological roles of them remain unknown 480 
(40).  481 
The present study and previous ones show that a major role of fatty acid activation 482 
is the utilization of endogenous fatty acids in organisms as diverse as S. cerevisiae, 483 
cyanobacteria, S. meliloti and E. coli. Probably, this mechanism is conserved in most 484 
organisms as suggested by Kaczmarzyk and Fulda (23). FadD has been studied mainly as 485 
an activity required for degradation of exogenous LCFA, and addition of exogenous fatty 486 
acids to the wild type S. meliloti increases the expression of the fadD gene (data not 487 
shown). However, the important role of FadD in utilization of endogenous free fatty acids 488 
was not recognized previously in bacteria. 489 
Fatty acids may act as environmental cues that control swarming motility in 490 
different bacteria. In Proteus mirabilis, oleic acid (C18:1Δ9) enhances swarming, 491 
whereas some saturated fatty acids inhibited this type of surface motility (30). Also in 492 
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Serratia marcescens saturated fatty acids negatively regulate swarming (29). 493 
Interestingly, in this bacterium a relationship between cellular fatty acid composition and 494 
swarming phenotypes has been observed leading to the hypothesis that modulation of 495 
cellular fatty acid composition and hence homeostasis of membrane fluidity may play a 496 
crucial role in controlling swarming motility. Seemingly contradictory to the previous 497 
results, swarming of Pseudomonas aeruginosa was not altered by the saturated fatty acids 498 
palmitic (C16:0) or stearic acid (C18:0) while oleic and vaccenic acid (C18:1Δ11) were 499 
inhibiting swarming (22). For the case of S. meliloti, none of the fatty acids tested 500 
(palmitic acid, stearic acid, or oleic acid at concentrations of 5 μg ml-1) were able to 501 
induce swarming of the GR4 strain (data not shown). While the addition of palmitic or 502 
stearic acid did not interfere with the swarming phenotype of strain QS77, oleic acid 503 
inhibited its swarming phenotype (data not shown). However, we still cannot rule out a 504 
function of fatty acids in swarming of S. meliloti since the wild type is able to metabolize 505 
fatty acids while the fadD mutant cannot use them. Further analysis of the lipidic 506 
composition presented under swarming inducing conditions by different S. meliloti strains 507 
will reveal whether membrane fluidity is involved in swarming as postulated by Lai et al. 508 
(30). 509 
In E. coli, acyl-CoAs resulting from FadD activity on long-chain fatty acids are 510 
able to bind to FadR, a repressor of the GntR family, which controls the expression of the 511 
fatty acid degradation genes. Binding of the acyl-CoAs to FadR causes release of the 512 
regulatory protein from the operator and thus derepression of the fad genes (40). Our data 513 
indicate that formation of acyl-CoAs is also required for activation of the fad regulon in 514 
S. meliloti, although the regulator probably involved, SMc01260, belongs to the MerR 515 
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family. Our experimental data are in agreement with the computationally identified 516 
regulatory network for fatty acid degradation in S. meliloti as well as with Kazakov’s 517 
proposal in which an acyl-CoA intermediate of the fatty acid degradation pathway might 518 
be the physiological effector controlling the expression of the smc01260 regulon. 519 
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FIGURE LEGENDS 696 
FIG. 1. S. meliloti fadD mutants accumulate fatty acids in the stationary phase of growth. 697 
(A) Cellular lipid extracts obtained either from wild type S. meliloti GR4 (fadD+) or from 698 
its fadD mutant QS77 (fadD-) grown till exponential phase (OD620= 0.7, 9 hours of 699 
growth); till early stationary phase (OD620= 1.2, 26 hours of growth) or till late stationary 700 
phase (50 hours of growth). (B) Lipid extracts of cultures grown till the early stationary 701 
phase (OD620= 1.2) of the S. meliloti strains: GR4 (fadD+) and its mutant derivative QS77 702 
(fadD-); 1021 (fadD+) and its mutant derivative 1021FDC5 (fadD-); QS77 carrying the 703 
empty vector pBBR1MCS-3 (fadD-) or carrying fadD-containing plasmid pBBRD4 704 
(fadD+). P: 14C-palmitic acid. Membrane lipids (ML) did not migrate from the origin and 705 
the spot for fatty acids (FA) is indicated. (C) Growth curves of strains GR4 () and 706 
QS77 () and quantification of their fatty acids: GR4 () and QS77 (); corresponding 707 
with TLC plate shown in (A). Quantification of the intensity of the spot for fatty acids is 708 
given in arbitrary units (au). Cultures were grown on Sherwood minimal medium. Similar 709 
results were obtained with cultures grown on Robertsen minimal medium.  710 
 711 
FIG. 2. Separation of 14C-acetate-labeled lipids of wild type S. meliloti 1021 (A) and the 712 
fadD-deficient mutant 1021FDC5 (B) by two-dimensional thin layer chromatography. 713 
Cultures were grown till early stationary phase (final OD620= 1.2) in Sherwood minimal 714 
medium. Fatty acids (FA) and the membrane lipids phosphatidylcholine (PC), 715 
phosphatidylethanolamine (PE), monomethyl-PE (MMPE), sulfolipid (SL), ornithine 716 
lipid (OL), phosphatidylglycerol (PG) and cardiolipin (CL) are indicated. 717 
 718 
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FIG. 3. Fatty acid profiles of lipid extracts from cells and spent culture media of wild 719 
type S. meliloti 1021 and fadD mutant 1021FDC5. (A) Free fatty acids in cell lipid 720 
extracts. (B) Esterified fatty acids in cell lipid extracts. (C) Free fatty acids in the culture 721 
medium. Concentrations are given as nmol ml-1 of culture. The inset in (A) depicts 722 
zoomed columns. For each strain three independent cultures were analyzed. The error 723 
bars represent the SD.  724 
 725 
FIG. 4. Expression of Δ5-des in S. meliloti 1021FDC5 leads to formation of Δ5-726 
unsaturated free fatty acids. Partial gas chromatograms of methyl esters obtained from 727 
fatty acids in the spent culture medium of 1021FCD5 carrying an empty vector (A) or 728 
expressing Δ5-des (B). The different fatty acids in (A) were confirmed by co-migration 729 
and by comparison of their mass spectra with authentic standards. The Δ5 modified fatty 730 
acids were identified by comparison with reported spectra (See Figs. S1 and S2). 731 
  732 
FIG. 5. fadD mutants of E. coli accumulate free fatty acids in late stationary phase of 733 
growth. (A) Growth curves of strains Y-Mel (), K-27 (pBBRD4) (), and K-27 734 
(pBBR1MCS-3) () and quantification of fatty acids: Y-Mel (), K-27 (pBBRD4) (), 735 
and K-27 (pBBR1MCS-3) (). Quantification of the intensity of the spot for fatty acids 736 
is given in arbitrary units (au). (B) Lipid extracts from cells or supernatants of E. coli 737 
strains: Y-Mel (Wt), YfadD1 (fadD-), YfadL1 (fadL-), K-27 (pBBRD4) (fadD- 738 
complemented with fadD from S. meliloti), K-27 (pBBR1MCS-3) (fadD-), and KfadL1  739 
(pBBR1MCS-3) (fadD- and fadL-). Lipid extracts were obtained from cultures grown till 740 
late stationary phase (26 hours). FA: fatty acids; membrane lipids (ML) did not migrate 741 
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from the origin; U: unidentified lipid. Cultures were grown on M9 minimal medium. The 742 
arrow in (A) indicates when samples shown in (B) were taken. 743 
 744 
FIG. 6. Fatty acid profiles of lipid extracts from cells and spent culture media of E. coli 745 
K-27 (fadD-) carrying S. meliloti fadD-containing plasmid pBBRD4 and K-27 carrying 746 
empty vector pBBR1MCS-3. (A) Free fatty acids in cell lipid extracts. (B) Esterified fatty 747 
acids in cell lipid extracts. (C) Free fatty acids in the culture medium. The inset in (A) 748 
depicts zoomed columns. For each strain two independent cultures were analyzed.  749 
 750 
FIG. 7. Distribution in functional categories of down-regulated genes in S. meliloti fadD 751 
mutant compared to the wild type strain. Functional categories have been assigned 752 
according to the S. meliloti Genome Project 753 
(http://iant.toulouse.inra.fr/bacteria/annotation/cgi/rhime.cgi).754 




Table 1. Bacterial strains and plasmids used in this work. 756 
Strain or 
plasmid 
Relevant characteristicsa Reference or 
source 
Escherichia coli   
DH5α recA1, Φ80 lacZ∆M1; cloning strain (21) 
S17-1 thi pro recA hsdR- hsdM+ RP4 integrated in the 
chromosome, 2-Tc::Mu, Km::Tn7(TpR/SmR  
(47) 
Y-Mel Wild type strain (38) 
K-27 fadD mutant derivative of Y-Mel (35) 
JW1794-1 BW25113 fadD::kan (4) 
JW2341-1 BW25113 fadL::kan (4) 
YfadD1 Y-Mel fadD::kan This work 
YfadL1 Y-Mel fadL::kan This work 




GR4 Wild type strain (11) 
QS77 fadD::Tn5 insertion mutant derivative of GR4, 
KmR 
(48) 
1021 SmR of SU47 wild type (19) 
1021FDC5 fadD mutant derivative of wild type 1021, SmR, (33) 




Plasmids   
pET17b Expression vector, CbR Novagen 
pBBR1MCS-3 Broad-host range vector, TcR (27) 
pBBRD4 pBBR1MCS-3 derivative harboring the fadD 
gene of S. meliloti GR4, TcR 
(48) 
pRK404  Broad-host range vector, TcR (14) 
pDM10 pHP13 derivative containing the ∆5-des gene of 
B. subtilis 
(1) 
pNG28 pET17b cloned in pRK404 This work 
pECH9 ∆5-des of B. subtilis in pET17b This work 
pRCanul5 pECH9 cloned in pRK404 This work 
aTcR, TpR, KmR, SmR, CbR, : tetracycline, trimethoprim, kanamycine, streptomycin, and 757 
carbenicillin resistance, respectively.  758 
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Table 2. Sequences of the oligonucleotides used for quantitative real-time PCR. 759 
Gene Forward Primer (5’ to 3’) Reverse Primer (5’ to 3’) 
smc03224 (16S rRNA) TCTACGGAATAACGCAGG GTGTCTCAGTCCCAATGT 
smc02227 (fadB) TCGATGAACGTCTTCACC CGGAGAAGGAGGATTTGC 
smc02229 GACATCCTCAGTCTGATG CGTGCTCTTCGATATAGC 
 760 
Table 3. Relative expression of fatty acid degradation genes in S. meliloti cultures at 761 
exponential (OD 0.8) and stationary (OD 1.2) phases of growth. 762 
 Relative expression ratio 1021 vs. 1021FDC5 a 
 Microarrays (OD 1.2)b RT-qPCR (OD 1.2)c RT-qPCR (OD 0.8)c 
smc02229 11.96 80.64 ± 28.93 -1.65 ± 0.22 
fadA 3.5 ND ND 
fadB 2.8 11.68 ± 4.9 1.18 ± 0.1 
 763 
a Data correspond to results obtained from cultures grown in Robertsen medium. Similar 764 
results were obtained from cultures grown in Sherwood medium (data not shown). 765 
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b Fold changes in gene expression obtained in the microarray experiment were calculated as 766 
2M 767 
c Fold changes in gene expression obtained in RT-qPCR were calculated from cycle 768 
threshold (Ct) values obtained from real-time PCR experiments using the comparative critical 769 
threshold (∆∆CT) method (36). The smc03224 gene coding for 16S rRNA was used as an internal 770 
control. Data are averages from two independent biological experiments with three technical 771 
replicates. The minus sign indicates decreased fold change in 1021. The standard errors of the 772 
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Genes differentially expressed in S. meliloti  1021FDC5 vs. Rm1021 in MM at the beginning of the stationary phase of growth. 
Only M values above 1 or below -1 with p≤0.05 are shown. 
The MerR -type regulator SMc01260 as well as genes predicted to belong to
the SMc01260 regulon for fatty acid degradation (Kazakov et al. 2009) are shown in red 
Down-regulated genes 
Gene ID Description M-value Classification
SMc02229 Putative acyl-CoA dehydrogenase -3.57917051 Small molecule metabolism
SMb20704 glgA2 Putative glycogen synthase -2.55110878 Macromolecule metabolism
SMc00885 Hypothetical transmembrane signal peptide protein -2.46055605 Partial homology
SMc00796 Hypothetical transmembrane protein -2.36512716 Global homology
SMc00371 Conserved hypothetical protein -2.27504709 Global homology
SMc01109 metK Probable S-adenosylmethionine synthetase -2.11927796 Central intermediary metabolism
SMc02255 qxtA Putative quinol oxidase subunit I transmembrane protein -2.09117265 Small molecule metabolism
SMb20302 Conserved hypothetical protein -2.03906977 Global homology
SMc01842 Probable transcriptional regulator -1.96160097 Not classified regulator
SMc01260 Putative transcription regulator -1.93058026 Not classified regulator
SMb21481 Conserved hypothetical protein -1.89489594 Global homology
SMa0134 conserved hypothetical protein -1.87963966 Global homology
SMc00041 Conserved hypothetical protein -1.8710781 Global homology
SMc00641 serA Putative D-3-phosphoglycerate dehydrogenase -1.8668014 Small molecule metabolism
SMc02050 tig Probable trigger factor -1.84704184 Cell processes
SMc01312 fusA1 Probable elongation factor G -1.82683803 Macromolecule metabolism
SMc01295 rpsH Probable 30S ribosomal protein S8 -1.81062191 Structural elements
SMc00567 rpsR Putative 30S ribosomal protein S18 -1.80135954 Structural elements
SMc01311 tufA Probable elongation factor TU protein -1.78767303 Macromolecule metabolism
SMc02228 fadA Putative acetyl-CoA acyltransferase -1.74526041 Small molecule metabolism
SMc01308 rplD Probable 50S ribosomal protein L4 -1.74319245 Structural elements
SMc02254 qxtB Putative quinol oxidase subunit II transmembrane protein -1.74134586 Small molecule metabolism
SMc01294 rplF Probable 50S ribosomal protein L6 -1.73128645 Structural elements
SMc00800 Hypothetical transmembrane protein -1.70291641 Partial homology
SMc01152 rpsT 30S ribosomal protein S20 -1.69525282 Structural elements
SMc00367 Conserved hypothetical protein -1.67957895 Global homology
SMc02499 atpA Probable ATP synthase subunit alpha -1.67716311 Small molecule metabolism
SMc01326 tufB Probable elongation factor TU protein -1.67342254 Macromolecule metabolism
SMb20228 ndiA 2 Putative nutrient deprivation-induced protein -1.6553055 Cell processes
SMb21441 Conserved hypothetical protein -1.64924889 Central intermediary metabolism
SMc01489 Conserved hypothetical signal peptide protein containing calcium-binding EF-hand regions -1.64642216 Global homology
SMc02500 atpG Probable ATP synthase gamma chain -1.64058373 Small molecule metabolism
SMa1225 FixK1 transcriptional regulator -1.63105362 Small molecule metabolism
SMc01297 rplE Probable 50S ribosomal protein L5 -1.62379801 Structural elements
SMc00485 rpsD Probable 30S ribosomal subunit protein S4 -1.61485561 Structural elements
SMc00640 serC Putative phosphoserine aminotransferase -1.61373121 Small molecule metabolism
SMc01309 rplC Probable 50S ribosomal protein L3 -1.61255363 Structural elements
SMc01313 rpsG Probable 30S ribosomal protein S7 -1.60904586 Structural elements
SMc01319 rplJ Probable 50S ribosomal protein L10 (L8) -1.60453716 Structural elements
SMc01967 speB2 Putative agmatinase -1.58050425 Central intermediary metabolism
SMc02755 ahcY Probable adenosylhomocysteinase -1.57258878 Central intermediary metabolism
SMc01310 rpsJ Probable 30S ribosomal protein S10 -1.55285187 Structural elements
SMc01299 rplN Probable 50S ribosomal protein L14 -1.53048193 Structural elements
SMa0744 groEL2 groEL2 chaperonin -1.52299307 Cell processes
SMc01296 rpsN Probable 30S ribosomal protein S14 -1.51859732 Structural elements
SMc02227 fadB Putative fatty oxidation complex alpha subunit includes: enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, 3-hydroxybutyryl-CoA epimerase transmembrane protein1.50759345 Small molecule metabolism
SMc00147 Conserved hypothetical protein -1.5066171 Global homology
SMc02124 cysI Putative sulfite reductase -1.49763093 Central intermediary metabolism
SMc01410 Putative lipoprotein transmembrane -1.49226264 Structural elements
SMc01298 rplX Probable 50S ribosomal protein L24 -1.47952782 Structural elements
SMa2353 oxidoreductase -1.46132625 Small molecule metabolism
SMc01292 rpsE Probable 30S ribosomal protein S5 -1.46130805 Structural elements
SMc02382 Conserved hypothetical protein -1.44714901 Global homology
SMb20198 cbbL Putative ribulose-1,5-bisphosphate carboxylase large subunit -1.43530222 Central intermediary metabolism
SMb21484 rpoE5 Putative RNA polymerase sigma-E factor (sigma-24) protein -1.42451527 Small molecule metabolism
SMc01307 rplW Probable 50S ribosomal protein L23 -1.39435065 Structural elements
SMa1223 FixM flavoprotein oxidoreductase -1.39431461 Small molecule metabolism
SMc00335 rpsA  30S ribosomal protein S1 -1.3834706 Structural elements
SMc01306 rplB Probable 50S ribosomal protein L2 -1.38017336 Structural elements
SMc02498 atpH Putative ATP synthase delta chain -1.36673962 Small molecule metabolism
SMc02150 Conserved hypothetical protein -1.36603257 Global homology
SMc01508 Hypothetical transmembrane protein -1.35412171 Partial homology
SMc01314 rpsL  Probable 30S ribosomal protein S12 -1.3521489 Structural elements
SMc01287 rpsM Probable 30S ribosomal protein S13 -1.34670877 Structural elements
SMc03112 metH Probable 5-methyltetrahydrofolate--homocysteine methyltransferase (methionine synthase, vitamin-B12 dependent isozyme) protein-1.34228879 Small molecule tab lism
SMb21480 Conserved hypothetical protein -1.33927971 Global homology
SMc00869 atpF2 Probable ATP synthase subunit B' transmembrane protein -1.33674148 Small molecule metabolism
SMa0762 FixK2 transcriptional regulator -1.3327474 Small molecule metabolism
SMb21357 Hypothetical membrane protein -1.32877481 Global homology
SMc01259 Hypothetical transmembrane protein -1.32086009 Global homology
SMc01843 metF Probable 5,10-methylenetetrahydrofolate reductase oxidoreductase -1.32079376 Central intermediary metabolism
SMc01305 rpsS Probable 30S ribosomal protein S19 -1.31284298 Structural elements
SMc00521 Conserved hypothetical protein -1.3050978 Global homology
SMc00913 groEL1  60 KD chaperonin A -1.27254213 Cell processes
SMc00063 Conserved hypothetical protein -1.27116112 Global homology
SMb21446 glgX2 Isoamylase -1.2676824 Macromolecule metabolism
SMc04434 rpmH Probable 50S ribosomal protein L34 -1.26593378 Structural elements
SMa1683 Arylsulfatase -1.26418496 Small molecule metabolism
SMc00660 Hypothetical signal peptide protein -1.26405417 Global homology
SMc01290 rplO Probable 50S ribosomal protein L15 -1.23391963 Structural elements
SMc00792 Hypothetical transmembrane protein -1.21780857 Global homology
SMa0113 Sensor histidine kinase -1.21294773 Not classified regulator
SMb21295 Putative small heat shock protein, hsp20 family -1.20022505 Cell processes
SMc00728 etfA1 Putative electron transfer flavoprotein alpha-subunit alpha-ETF flavoprotein -1.18642861 Small molecule metabolism
SMb20200 cbbT Putative transketolase -1.18337995 Central intermediary metabolism
SMa0114 Two-component response regulator -1.1815887 Not classified regulator
SMc01803 rpsI Probable 30S ribosomal protein S9 -1.17144563 Structural elements
SMc00323 rpsO Probable 30S ribosomal protein S15 -1.1658824 Structural elements
SMc01467 Conserved hypothetical protein, signal peptide -1.16164464 Global homology
SMa2071 Hypothetical protein -1.15445751 Unknown
SMc02472 Putative transport system permease ABC transporter -1.13653795 Cell processes
SMc01318 rplL Probable 50S ribosomal protein L7/L12 (L8) -1.12707174 Structural elements
SMc01304 rplV Probable 50S ribosomal protein L22 -1.11714586 Structural elements
SMc00324 pnp Probable polyribonucleotide nucleotidyltransferase -1.10969079 Macromolecule metabolism
SMa1672 conserved hypothetical protein -1.09888924 Partial homology
SMc00704 rpmB Probable 50S ribosomal protein L28 -1.0911328 Structural elements
SMc03038 flaB Flagellin B -1.08949899 Cell processes
SMc01966 Putative spermidine/putrescine-binding periplasmic ABC transporter -1.08768598 Cell processes
SMc01266 Conserved hypothetical protein -1.0829151 Global homology
SMc01291 rpmD Probable 50S ribosomal protein L30 -1.08273153 Structural elements
SMc02911 Conserved hypothetical protein -1.08139903 Global homology
SMb20605 ABC transporter, periplasmic solute-binding protein -1.07751737 Cell processes
SMa1391 etfB2 EtfB2 electron transport flavoprotein, beta subunit -1.06495076 Small molecule metabolism
SMc03802 Putative peptidase -1.05799366 Macromolecule metabolism
SMc03110 Conserved hypothetical protein -1.05738655 Global homology
SMb20933 exsG Putative two-component sensor histidine kinase -1.05668845 Small molecule metabolism
SMa1389 etfA2 EtfA2 electron-transport flavoprotein, alpha-subunit -1.05472853 Small molecule metabolism
SMa2063 Sensor histidine kinase -1.05259765 Not classified regulator
SMc04009 Conserved hypothetical protein -1.0478243 Global homology
SMb21473 Conserved hypothetical protein -1.04500378 Global homology
SMb21198 oppC ABC transporter of tetrapeptides and some tripeptides, permease component -1.04477407 Cell processes
SMb21197 oppB ABC transporter of tetrapeptides and some tripeptides, permease component -1.03782123 Cell processes
SMb20966 lacZ2 Putative beta-galactosidase putative beta galactosidase protein Oligonucleotide 15140978...-1.03744276 Small molecule metabolism
SMb20194 Conserved hypothetical protein -1.03464019 Global homology
SMc03111 pmi Mannose-6-phosphate isomerase -1.03044053 Small molecule metabolism
SMc00729 etfB1 Putative electron transfer flavoprotein beta-subunit beta-ETF flavoprotein small subunit -1.02587681 Small molecule metabolism
SMb20227 ndiA 1 Putative nutrient deprivation-induced protein -1.02287498 Cell processes
SMc02467 mrsA2 Probable peptide methionine sulfoxide reductase MsrA 2 -1.0139935 Macromolecule metabolism
SMb21333 Hypothetical protein -1.00787562 Partial homology
SMc02123 Sulfate or sulfite assimilation protein -1.0077925 Central intermediary metabolism
Up-regulated genes 
Gene ID Description M-value Classification
nptII Oligonucleotide nptII... 6.77351857
SMb20473 Hypothetical protein 1.76218645 Global homology
SMc01660 Conserved hypothetical protein 1.15545557 Global homology
SMb20513 Hypothetical protein 1.14094699 Global homology
SMc03776 proB1 Probable glutamate 5-kinase 1.10488464 Small molecule metabolism
SMa0520 Transcriptional regulator, RpiR family 1.06137078 Not classified regulator
SMa1354 Isomerase 1.03653894 Small molecule metabolism
SMc03168 Multidrug resistance efflux system 1.0143509 Cell processes
